カテゴリー： GlobalInfoResearch, 世界

糖鎖生物学（診断と治療）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Glycobiology (Diagnostics and Therapeutics) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102025）・商品コード：GIR9102025
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月16日（※2024年版があります。お問い合わせください）
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、糖鎖生物学（診断と治療）の世界市場について調べ、まとめました。種類別セグメントは、診断、治療学等、用途別セグメントは、クリニック、病院、その他等に区分しました。糖鎖生物学（診断と治療）の世界市場概観、企業動向、企業別糖鎖生物学（診断と治療）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・糖鎖生物学（診断と治療）の市場概観
・糖鎖生物学（診断と治療）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・糖鎖生物学（診断と治療）の企業別販売動向、市場シェア、市場集中度、競争動向
・糖鎖生物学（診断と治療）の世界市場規模
・糖鎖生物学（診断と治療）の北米市場分析（アメリカ、カナダ、メキシコ等）
・糖鎖生物学（診断と治療）のアメリカ市場規模推移
・糖鎖生物学（診断と治療）のカナダ市場規模推移
・糖鎖生物学（診断と治療）のメキシコ市場規模推移
・糖鎖生物学（診断と治療）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・糖鎖生物学（診断と治療）のドイツ市場規模推移
・糖鎖生物学（診断と治療）のイギリス市場規模推移
・糖鎖生物学（診断と治療）のロシア市場規模推移
・糖鎖生物学（診断と治療）のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・糖鎖生物学（診断と治療）の日本市場規模推移
・糖鎖生物学（診断と治療）の中国市場規模推移
・糖鎖生物学（診断と治療）の韓国市場規模推移
・糖鎖生物学（診断と治療）のインド市場規模推移
・糖鎖生物学（診断と治療）の東南アジア市場規模推移
・糖鎖生物学（診断と治療）の南米市場分析（ブラジル、アルゼンチン等）
・糖鎖生物学（診断と治療）の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・糖鎖生物学（診断と治療）の種類別分析/販売量、売上、市場シェア（診断、治療学）
・糖鎖生物学（診断と治療）の用途別分析/市場規模（クリニック、病院、その他）
・糖鎖生物学（診断と治療）の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・糖鎖生物学（診断と治療）の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research.

Scope of the Report:
Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function.
Glycosylation defines the adhesive properties of proteins and cells. The immune system largely functions via glycan-protein interactions, which highlights the importance of glycans in physiology, pathogen recognition, cancer and autoimmune diseases.
Glycan molecules modulate many other processes important for cell and tissue differentiation, metabolic and gene regulation, protein activity, protein clearance, transport and more.
The global Glycobiology (Diagnostics and Therapeutics) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glycobiology (Diagnostics and Therapeutics).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Glycobiology (Diagnostics and Therapeutics) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glycobiology (Diagnostics and Therapeutics) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Biomarin Pharmaceutical Inc.
Glycomimetics
Glycan Biosciences Llc
Glycosensors And Diagnostics Llc
Glycotest Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diagnostics
Therapeutics

Market Segment by Applications, can be divided into
Clinic
Hospital
Other

【レポートの目次】

Table of Contents

1 Glycobiology (Diagnostics and Therapeutics) Market Overview
1.1 Product Overview and Scope of Glycobiology (Diagnostics and Therapeutics)
1.2 Classification of Glycobiology (Diagnostics and Therapeutics) by Types
1.2.1 Global Glycobiology (Diagnostics and Therapeutics) Revenue Comparison by Types (2019-2024)
1.2.2 Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Types in 2018
1.2.3 Diagnostics
1.2.4 Therapeutics
1.3 Global Glycobiology (Diagnostics and Therapeutics) Market by Application
1.3.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Other
1.4 Global Glycobiology (Diagnostics and Therapeutics) Market by Regions
1.4.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Glycobiology (Diagnostics and Therapeutics) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Glycobiology (Diagnostics and Therapeutics) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Glycobiology (Diagnostics and Therapeutics) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Glycobiology (Diagnostics and Therapeutics) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Glycobiology (Diagnostics and Therapeutics) Status and Prospect (2014-2024)
1.5 Global Market Size of Glycobiology (Diagnostics and Therapeutics) (2014-2024)
2 Manufacturers Profiles
2.1 Biomarin Pharmaceutical Inc.
2.1.1 Business Overview
2.1.2 Glycobiology (Diagnostics and Therapeutics) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Biomarin Pharmaceutical Inc. Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Glycomimetics
2.2.1 Business Overview
2.2.2 Glycobiology (Diagnostics and Therapeutics) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Glycomimetics Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
2.3 Glycan Biosciences Llc
2.3.1 Business Overview
2.3.2 Glycobiology (Diagnostics and Therapeutics) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Glycan Biosciences Llc Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Glycosensors And Diagnostics Llc
2.4.1 Business Overview
2.4.2 Glycobiology (Diagnostics and Therapeutics) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Glycosensors And Diagnostics Llc Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
2.5 Glycotest Inc.
2.5.1 Business Overview
2.5.2 Glycobiology (Diagnostics and Therapeutics) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Glycotest Inc. Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Glycobiology (Diagnostics and Therapeutics) Market Competition, by Players
3.1 Global Glycobiology (Diagnostics and Therapeutics) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Glycobiology (Diagnostics and Therapeutics) Players Market Share
3.2.2 Top 10 Glycobiology (Diagnostics and Therapeutics) Players Market Share
3.3 Market Competition Trend
4 Global Glycobiology (Diagnostics and Therapeutics) Market Size by Regions
4.1 Global Glycobiology (Diagnostics and Therapeutics) Revenue and Market Share by Regions
4.2 North America Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
4.3 Europe Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
4.5 South America Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
5 North America Glycobiology (Diagnostics and Therapeutics) Revenue by Countries
5.1 North America Glycobiology (Diagnostics and Therapeutics) Revenue by Countries (2014-2019)
5.2 USA Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
5.3 Canada Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
5.4 Mexico Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
6 Europe Glycobiology (Diagnostics and Therapeutics) Revenue by Countries
6.1 Europe Glycobiology (Diagnostics and Therapeutics) Revenue by Countries (2014-2019)
6.2 Germany Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
6.3 UK Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
6.4 France Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
6.5 Russia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
6.6 Italy Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue by Countries
7.1 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue by Countries (2014-2019)
7.2 China Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
7.3 Japan Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
7.4 Korea Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
7.5 India Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
8 South America Glycobiology (Diagnostics and Therapeutics) Revenue by Countries
8.1 South America Glycobiology (Diagnostics and Therapeutics) Revenue by Countries (2014-2019)
8.2 Brazil Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
8.3 Argentina Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
8.4 Colombia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Glycobiology (Diagnostics and Therapeutics) by Countries
9.1 Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
9.3 UAE Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
9.4 Egypt Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
9.6 South Africa Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
10 Global Glycobiology (Diagnostics and Therapeutics) Market Segment by Type
10.1 Global Glycobiology (Diagnostics and Therapeutics) Revenue and Market Share by Type (2014-2019)
10.2 Global Glycobiology (Diagnostics and Therapeutics) Market Forecast by Type (2019-2024)
10.3 Diagnostics Revenue Growth Rate (2014-2024)
10.4 Therapeutics Revenue Growth Rate (2014-2024)
11 Global Glycobiology (Diagnostics and Therapeutics) Market Segment by Application
11.1 Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Application (2014-2019)
11.2 Glycobiology (Diagnostics and Therapeutics) Market Forecast by Application (2019-2024)
11.3 Clinic Revenue Growth (2014-2019)
11.4 Hospital Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2024)
12.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2024)
12.2 Global Glycobiology (Diagnostics and Therapeutics) Market Forecast by Regions (2019-2024)
12.3 North America Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
12.4 Europe Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
12.6 South America Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Glycobiology (Diagnostics and Therapeutics) Picture
Table Product Specifications of Glycobiology (Diagnostics and Therapeutics)
Table Global Glycobiology (Diagnostics and Therapeutics) and Revenue (Million USD) Market Split by Product Type
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Types in 2018
Figure Diagnostics Picture
Figure Therapeutics Picture
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) by Application (2014-2024)
Figure Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Applications in 2018
Figure Clinic Picture
Figure Hospital Picture
Figure Other Picture
Table Global Market Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate (2014-2024)
Table Biomarin Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table Biomarin Pharmaceutical Inc. Glycobiology (Diagnostics and Therapeutics) Type and Applications
Table Biomarin Pharmaceutical Inc. Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
Table Glycomimetics Basic Information, Manufacturing Base and Competitors
Table Glycomimetics Glycobiology (Diagnostics and Therapeutics) Type and Applications
Table Glycomimetics Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
Table Glycan Biosciences Llc Basic Information, Manufacturing Base and Competitors
Table Glycan Biosciences Llc Glycobiology (Diagnostics and Therapeutics) Type and Applications
Table Glycan Biosciences Llc Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
Table Glycosensors And Diagnostics Llc Basic Information, Manufacturing Base and Competitors
Table Glycosensors And Diagnostics Llc Glycobiology (Diagnostics and Therapeutics) Type and Applications
Table Glycosensors And Diagnostics Llc Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
Table Glycotest Inc. Basic Information, Manufacturing Base and Competitors
Table Glycotest Inc. Glycobiology (Diagnostics and Therapeutics) Type and Applications
Table Glycotest Inc. Glycobiology (Diagnostics and Therapeutics) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) by Players (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Players (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Players in 2017
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Players in 2018
Figure Global Top 5 Players Glycobiology (Diagnostics and Therapeutics) Revenue Market Share in 2018
Figure Global Top 10 Players Glycobiology (Diagnostics and Therapeutics) Revenue Market Share in 2018
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) by Regions (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Regions (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Regions (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Regions in 2018
Figure North America Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Europe Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure South America Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Table North America Glycobiology (Diagnostics and Therapeutics) Revenue by Countries (2014-2019)
Table North America Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure North America Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure North America Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries in 2018
Figure USA Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Canada Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Mexico Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Table Europe Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure Europe Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries in 2018
Figure Germany Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure UK Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure France Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Russia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Italy Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries in 2018
Figure China Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Japan Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Korea Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure India Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Table South America Glycobiology (Diagnostics and Therapeutics) Revenue by Countries (2014-2019)
Table South America Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure South America Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure South America Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries in 2018
Figure Brazil Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Argentina Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Colombia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure UAE Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Egypt Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure Nigeria Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Figure South Africa Glycobiology (Diagnostics and Therapeutics) Revenue and Growth Rate (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) by Type (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Type (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Type (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Type in 2019
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue Forecast by Type (2019-2024)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Share Forecast by Type (2019-2024)
Figure Global Diagnostics Revenue Growth Rate (2014-2019)
Figure Global Therapeutics Revenue Growth Rate (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue by Application (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Application (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Application (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Share by Application in 2019
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue Forecast by Application (2019-2024)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Share Forecast by Application (2019-2024)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
Figure Europe Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
Figure South America Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Glycobiology (Diagnostics and Therapeutics) Revenue Market Forecast (2019-2024)


【掲載企業】

Biomarin Pharmaceutical Inc.、Glycomimetics、Glycan Biosciences Llc、Glycosensors And Diagnostics Llc、Glycotest Inc.、

★調査レポート[糖鎖生物学（診断と治療）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102025)販売に関する免責事項を必ずご確認ください。
★調査レポート[糖鎖生物学（診断と治療）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 人工多能性幹細胞（iPSC）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103577 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、人工多能性幹細胞（iPSC）の世界市場について調べ、まとめました。種類別セグメントは、ヒトiPSC、マウスiPSC等、用途別セグメントは、学術研究、医薬品の開発と発見、毒性スクリーニング、再生医学等に区分しました。人工多能性幹細胞（iPSC）の世界市場概観、企業動向、企業別人工多能性幹細胞（iPSC）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・人工多能性幹細胞（iPSC）の市場概観 ・人工多能性幹細胞（iPSC）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・人工多能性幹細胞（iPSC）の企業別販売動向、市場シェア、市場集中度、競争動向 ・人工多能性幹細胞（iPSC）の世界市場規模 ・人工多能性幹細胞（iPSC）の北米市場分析（アメリカ、カナダ、メキシコ等） ・人工多能性幹細胞（iPSC）のアメリカ市場規模推移 ・人工多能性幹細胞（iPSC）のカナダ市場規模推移 ・人工多能性幹細胞（iPSC）のメキシコ市場規模推移 ・人工多能性幹細胞（iPSC）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Induced Pluripotent Stem Cells (iPSCs) market is valued at 74 million USD in 2018 and is expected to reach 114.9 million USD by the end of 2024, growing at a CAGR of 11.7% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Induced Pluripotent Stem Cells (iPSCs). Europe also...
  • MEMS（バイオセンサーおよびナノセンサー）の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102032 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、MEMS（バイオセンサーおよびナノセンサー）の世界市場について調べ、まとめました。種類別セグメントは、バイオセンサー、ナノセンサー等、用途別セグメントは、自動車、ライフサイエンス、消費者製品、プロセス産業、情報技術、軍事/航空宇宙/公共安全、エネルギー/環境、その他等に区分しました。MEMS（バイオセンサーおよびナノセンサー）の世界市場概観、メーカー動向、メーカー別MEMS（バイオセンサーおよびナノセンサー）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・MEMS（バイオセンサーおよびナノセンサー）の市場概観 ・MEMS（バイオセンサーおよびナノセンサー）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・MEMS（バイオセンサーおよびナノセンサー）の企業別販売動向、市場シェア、市場集中度、競争動向 ・MEMS（バイオセンサーおよびナノセンサー）の世界市場規模 ・MEMS（バイオセンサーおよびナノセンサー）の北米市場分析（アメリカ、カナダ、メキシコ等） ・MEMS（バイオセンサーおよびナノセンサー）のアメリカ市場規模推移 ・MEMS（バイオセンサーおよびナノセンサー）のカナダ市場規模推移 ・MEMS（バイオセンサーおよびナノセンサー）のメキシコ市場規模推移 ・MEMS（バイオセンサーおよびナノセンサー）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Micro-Electro-Mechanical Systems, or MEMS, is a technology that in its most general form can be defined as miniaturized mechanical and electro-mechanical elements (i.e., devices and structures) that are made using the techniques of microfabrication. MEMS technology integrates four components: microsensors, microactuators, microelectronics, and microstructures in a silicon chip. Biochips aremicrotechnology based microsensors which are used for the delivery, analysis, processing and detection of proteins, DNA, microorganisms or nucleic acids. Nanosensors are used to detect nanoparticles or any other nanoscaled parameters. Scope of the Report: The worldwide market for MEMS (Biosensors and Nanosensors) is expected to grow at a CAGR of...
  • エルゴチオネイン（EGT）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103581 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、エルゴチオネイン（EGT）の世界市場について調べ、まとめました。種類別セグメントは、エルゴチオネイン（EGT）、タイプII 等、用途別セグメントは、医療、食品産業、化粧品等に区分しました。エルゴチオネイン（EGT）の世界市場概観、企業動向、企業別エルゴチオネイン（EGT）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エルゴチオネイン（EGT）の市場概観 ・エルゴチオネイン（EGT）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エルゴチオネイン（EGT）の企業別販売動向、市場シェア、市場集中度、競争動向 ・エルゴチオネイン（EGT）の世界市場規模 ・エルゴチオネイン（EGT）の北米市場分析（アメリカ、カナダ、メキシコ等） ・エルゴチオネイン（EGT）のアメリカ市場規模推移 ・エルゴチオネイン（EGT）のカナダ市場規模推移 ・エルゴチオネイン（EGT）のメキシコ市場規模推移...Description Scope of the Report: The global Ergothioneine (EGT) market is valued at 6 million USD in 2018 and is expected to reach 18 million USD by the end of 2024, growing at a CAGR of 30.7% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ergothioneine (EGT). Europe also play important roles in global market,...
  • 保全用の電圧低下（CVR）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103603 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、保全用の電圧低下（CVR）の世界市場について調べ、まとめました。種類別セグメントは、ローカル制御、協調制御等、用途別セグメントは、産業用、商業用、住宅用等に区分しました。保全用の電圧低下（CVR）の世界市場概観、企業動向、企業別保全用の電圧低下（CVR）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・保全用の電圧低下（CVR）の市場概観 ・保全用の電圧低下（CVR）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・保全用の電圧低下（CVR）の企業別販売動向、市場シェア、市場集中度、競争動向 ・保全用の電圧低下（CVR）の世界市場規模 ・保全用の電圧低下（CVR）の北米市場分析（アメリカ、カナダ、メキシコ等） ・保全用の電圧低下（CVR）のアメリカ市場規模推移 ・保全用の電圧低下（CVR）のカナダ市場規模推移 ・保全用の電圧低下（CVR）のメキシコ市場規模推移 ・保全用の電圧低下（CVR）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Conservation Voltage Reduction（CVR） market is valued at 168.3 million USD in 2018 and is expected to reach 514.7 million USD by the end of 2024, growing at a CAGR of 32.2% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Conservation Voltage Reduction（CVR）. Europe also play important roles in...
  • 医療情報交換 (HIE) の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103685 / GlobalInfoResearch / 2019年9月30日 / 本調査レポートは、医療情報交換 (HIE) の世界市場について調べ、まとめました。種類別セグメントは、EHRベンダー薬用HIE、非EHRベンダーHIE等、用途別セグメントは、ディレクテッドエクスチェンジ、クエリベースエクスチェンジ、消費者仲介取引所等に区分しました。医療情報交換 (HIE) の世界市場概観、企業動向、企業別医療情報交換 (HIE) シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・医療情報交換 (HIE) の市場概観 ・医療情報交換 (HIE) の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・医療情報交換 (HIE) の企業別販売動向、市場シェア、市場集中度、競争動向 ・医療情報交換 (HIE) の世界市場規模 ・医療情報交換 (HIE) の北米市場分析（アメリカ、カナダ、メキシコ等） ・医療情報交換 (HIE) のアメリカ市場規模推移 ・医療情報交換 (HIE) のカナダ市場規模推移 ・医療情報交換 (HIE) のメキシコ市場規模推移 ・医療情報交換 (HIE) のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Health Information Exchange (HIE) market is valued at 942 million USD in 2018 and is expected to reach 1399.9 million USD by the end of 2024, growing at a CAGR of 10.4% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Health Information Exchange (HIE). Europe also play important...
  • インモールドエレクトロニクス（IME）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100331 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、インモールドエレクトロニクス（IME）の世界市場について調べ、まとめました。種類別セグメントは、銀導電性インク材料、炭素導電性インク材料、その他等、用途別セグメントは、家電、自動車、家電、産業、その他等に区分しました。インモールドエレクトロニクス（IME）の世界市場概観、企業動向、企業別インモールドエレクトロニクス（IME）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・インモールドエレクトロニクス（IME）の市場概観 ・インモールドエレクトロニクス（IME）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・インモールドエレクトロニクス（IME）の企業別販売動向、市場シェア、市場集中度、競争動向 ・インモールドエレクトロニクス（IME）の世界市場規模 ・インモールドエレクトロニクス（IME）の北米市場分析（アメリカ、カナダ、メキシコ等） ・インモールドエレクトロニクス（IME）のアメリカ市場規模推移 ・インモールドエレクトロニクス（IME）のカナダ市場規模推移 ・インモールドエレクトロニクス（IME）のメキシコ市場規模推移 ・インモールドエレクトロニクス（IME）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global In-mold electronics (IME) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In-mold electronics (IME). Europe also play important roles in...

    • ◆H&Iグローバルリサーチのお客様（例）◆